Measuring ART Adherence Among Young Adults with Perinatally Acquired HIV: Comparison Between Self-report, Telephone-Based Pill Count, and Objective Pharmacologic Measures

AIDS Behav. 2023 Dec;27(12):3927-3931. doi: 10.1007/s10461-023-04107-y. Epub 2023 Jun 16.

Abstract

Tenofovir diphosphate (TVF-DP) can be quantified in red blood cells (RBCs) and dried blood spots (DBS) and can objectively measure ART adherence and predict viral suppression. Data on the association of TFV-DP with viral load are very limited in adolescents and young adults (AYA) living with perinatally-acquired HIV (PHIV), as are data comparing TFV-DP to other measures of ART adherence, such as self-report and unannounced telephone pill count. Viral load and ART adherence (self-report, TFV-DP and unannounced telephone pill count) were assessed and compared among 61 AYAPHIV recruited from an ongoing longitudinal study (CASAH) in New York City.

Keywords: ART; Adherence; Measures; Perinatal HIV infection; Self-report; Tenofovir diphosphate; Unannounced telephone pill count.

MeSH terms

  • Adolescent
  • Anti-HIV Agents* / therapeutic use
  • HIV Infections* / drug therapy
  • Humans
  • Longitudinal Studies
  • Medication Adherence
  • Self Report
  • Telephone
  • Young Adult

Substances

  • Anti-HIV Agents